AMSub 13 SEP Parti F S762 AWS
. . . PARTICIPATING FACULTY . . . Clinical and Economic Considerations of Depression Management: A Managed Care Approach Proceedings in this Special Report supplement to The American Journal of Managed Care are based on presentations and roundtable discussions that took place in Scottsdale, Arizona on April 16 and 17, 1999.
SYMPOSIUM PANEL AND FACULTY Chairs Peter Rabins, MD Professor of Psychiatry Johns Hopkins University School of Medicine Baltimore, Maryland
Glenn Treisman, MD Associate Professor of Psychiatry Johns Hopkins University School of Medicine Baltimore, Maryland
Panel Members Jayendra Choksi, MD Medical Director Comprehensive Behavioral Care, Inc. Tampa, Florida Henry Cohen, MS, PharmD Associate Professor of Pharmacy Practice Arnold and Marie Schwartz College of Pharmacy and Health Sciences Long Island University Kingsbrook Jewish Medical Center Brooklyn, New York Timothy Jack, MD Chair, Prevention Services Medical Director HealthPlan Solutions Columbia, Maryland Wayne Katon, MD Professor, Vice Chair Director of Health Services and Epidemiology Department of Psychiatry and Behavioral Sciences University of Washington Seattle, Washington
S762
Michael S. Klinkman, MD Associate Professor Department of Family Medicine University of Michigan Medical Center Briarwood Family Practice Center Ann Arbor, Michigan Michael Nichol, PhD Associate Professor and Chair Department of Pharmaceutical Economics and Policy University of Southern California School of Pharmacy Los Angeles, California Jerome Vaccaro, MD Vice President Corporate Medical Director PacifiCare Behavioral Health Inc. Van Nuys, California Daniel R. Wilson, MD, PhD Professor of Psychiatry University of Cincinnati Medical Director, Intensive and Specialized Services Cincinnati, Ohio
THE AMERICAN JOURNAL OF MANAGED CARE
SEPTEMBR 1999
DISCLOSURE STATEMENT It is the policy of The American Journal of Managed Care to have all faculty who participate in programs sponsored by corporate organizations disclose any real or apparent conflicts of interest. These participants have declared the following affiliations with corporate organizations.
■
Henry Cohen, MS, PharmD
■
■
Wayne Katon, MD Advisory Board Member For: SmithKline Beecham
■
Peter Rabins, MD Grant Support From: Janssen Lecture Support From: Eli Lilly & Company Pfizer, Inc. Wyeth Ayerst Laboratories Eisai
Research Support From: Bristol-Myers Squibb Lecture Support From: Merck & Company Consultant For: Rhône-Poulnec-Rorer Pharmaceuticals
Michael Nichol, PhD Grant Support From: Amgen Bristol-Myers Squibb Eli Lilly & Company Pharmacia Upjohn Consultant For: Astra-Merck Allergan Parke-Davis
■
Glenn Treisman, MD Lecture Support From: Eli Lilly & Company Glaxo Wellcome Pfizer, Inc. Parke-Davis SmithKline Beecham Bristol-Myers Squibb Wyeth Ayerst
Daniel R. Wilson, MD, PhD Research/Lecture Support From: Pfizer, Inc. Research Support From/Consultant To: Eli Lilly & Company Janssen
The participants listed below declare no financial arrangements or affiliations with any corporate organizations. ■
Michael S. Klinkman, MD
■
Timothy Jack, MD
■
Jerome Vaccaro, MD
■
Jayendra Choksi, MD
VOL. 5, NO. 13, SUP.
THE AMERICAN JOURNAL OF MANAGED CARE
S763
SYMPOSIUM PANEL AND FACULTY Chairs Peter Rabins, MD Professor of Psychiatry Johns Hopkins University School of Medicine Baltimore, Maryland
Glenn Treisman, MD Associate Professor of Psychiatry Johns Hopkins University School of Medicine Baltimore, Maryland
Panel Members Jayendra Choksi, MD Medical Director Comprehensive Behavioral Care, Inc. Tampa, Florida Henry Cohen, MS, PharmD Associate Professor of Pharmacy Practice Arnold and Marie Schwartz College of Pharmacy and Health Sciences Long Island University Kingsbrook Jewish Medical Center Brooklyn, New York Timothy Jack, MD Chair, Prevention Services Medical Director HealthPlan Solutions Columbia, Maryland Wayne Katon, MD Professor, Vice Chair Director of Health Services and Epidemiology Department of Psychiatry and Behavioral Sciences University of Washington Seattle, Washington
S762
Michael S. Klinkman, MD Associate Professor Department of Family Medicine University of Michigan Medical Center Briarwood Family Practice Center Ann Arbor, Michigan Michael Nichol, PhD Associate Professor and Chair Department of Pharmaceutical Economics and Policy University of Southern California School of Pharmacy Los Angeles, California Jerome Vaccaro, MD Vice President Corporate Medical Director PacifiCare Behavioral Health Inc. Van Nuys, California Daniel R. Wilson, MD, PhD Professor of Psychiatry University of Cincinnati Medical Director, Intensive and Specialized Services Cincinnati, Ohio
THE AMERICAN JOURNAL OF MANAGED CARE
SEPTEMBR 1999
DISCLOSURE STATEMENT It is the policy of The American Journal of Managed Care to have all faculty who participate in programs sponsored by corporate organizations disclose any real or apparent conflicts of interest. These participants have declared the following affiliations with corporate organizations.
■
Henry Cohen, MS, PharmD
■
■
Wayne Katon, MD Advisory Board Member For: SmithKline Beecham
■
Peter Rabins, MD Grant Support From: Janssen Lecture Support From: Eli Lilly & Company Pfizer, Inc. Wyeth Ayerst Laboratories Eisai
Research Support From: Bristol-Myers Squibb Lecture Support From: Merck & Company Consultant For: Rhône-Poulnec-Rorer Pharmaceuticals
Michael Nichol, PhD Grant Support From: Amgen Bristol-Myers Squibb Eli Lilly & Company Pharmacia Upjohn Consultant For: Astra-Merck Allergan Parke-Davis
■
Glenn Treisman, MD Lecture Support From: Eli Lilly & Company Glaxo Wellcome Pfizer, Inc. Parke-Davis SmithKline Beecham Bristol-Myers Squibb Wyeth Ayerst
Daniel R. Wilson, MD, PhD Research/Lecture Support From: Pfizer, Inc. Research Support From/Consultant To: Eli Lilly & Company Janssen
The participants listed below declare no financial arrangements or affiliations with any corporate organizations. ■
Michael S. Klinkman, MD
■
Timothy Jack, MD
■
Jerome Vaccaro, MD
■
Jayendra Choksi, MD
VOL. 5, NO. 13, SUP.
THE AMERICAN JOURNAL OF MANAGED CARE
S763
